Unknown

Dataset Information

0

RbYb(PO3)4.

ABSTRACT: Rubidium ytterbium(III) tetra-kis-(polyphosphate), RbYb(PO3)4, was synthesized by solid-state reaction. It adopts structure type IV of the MRE(PO3)4 (M = alkali metal and RE = rare earth metal) family of compounds. The structure is composed of a three-dimensional framework made up from double spiral polyphosphate chains parallel to [10-1] and irregular [YbO8] polyhedra. There are eight PO4 tetra-hedra in the repeat unit of the polyphosphate chains. The Rb(+) cation is located in channels extending along [100] that are delimited by the three-dimensional framework. It is surrounded by 11 O atoms, defining an irregular polyhedron.

SUBMITTER: Zhu J 

PROVIDER: S-EPMC3588346 | biostudies-other | 2013 Jan

REPOSITORIES: biostudies-other

Json Xml
altmetric image

Publications

RbYb(PO3)4.

Zhu Jing J   Chen Hui H  

Acta crystallographica. Section E, Structure reports online 20121222 Pt 1

Rubidium ytterbium(III) tetra-kis-(polyphosphate), RbYb(PO3)4, was synthesized by solid-state reaction. It adopts structure type IV of the MRE(PO3)4 (M = alkali metal and RE = rare earth metal) family of compounds. The structure is composed of a three-dimensional framework made up from double spiral polyphosphate chains parallel to [10-1] and irregular [YbO8] polyhedra. There are eight PO4 tetra-hedra in the repeat unit of the polyphosphate chains. The Rb(+) cation is located in channels extendi  ...[more]

Similar Datasets

Unknown LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 5 of 15: End-point mean cell counts and mean normalized growth rate inhibition values for biological replicate 2.
2017-05-12 | LDS-1412 | LINCS
Unknown LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1.
2017-05-12 | LDS-1408 | LINCS
Unknown LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3.
2017-05-12 | LDS-1410 | LINCS
Unknown LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 4 of 9: Mean cell count and mean normalized growth rate inhibition values for biological replicate 1
2017-02-07 | LDS-1376 | LINCS
Unknown Breast Cancer Profiling Project, Drug Sensitivity 1: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens. Dataset 1 of 2: Normalized growth rate inhibition values.
2018-03-30 | LDS-1518 | LINCS
Unknown Sensitivity measures of MDA-MB-231 and HME-1 cell lines to LINCS Pilot Phase TransCenter Project kinase inhibitors
2015-07-01 | LDS-1206 | LINCS
Unknown LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3.
2017-03-14 | LDS-1228 | LINCS
Unknown Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 2 of 2: Calculated dose response metrics
2019-06-27 | LDS-1562 | LINCS
Unknown LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Repeat performed by Scientist B in 2019 to assess reproducibility. Dataset 1 of 2: Normalized growth rate inhibition values.
2019-06-27 | LDS-1564 | LINCS
Unknown LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Repeat performed by Scientist A in 2019 to assess reproducibility. Dataset 1 of 2: Normalized growth rate inhibition values.
2019-06-27 | LDS-1563 | LINCS